Gilead Sciences, Inc. (GILD)

Last Closing Price: 168.98 (2026-11-18)

Cost of Goods Sold (Quarterly)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

Gilead Sciences, Inc. (GILD) had Cost of Goods Sold of $1.57B for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$8.30B
$2.43B
Cost of Goods Sold
$1.57B
$6.73B
$4.84B
$3.46B
$-399.00M
$3.06B
$3.06B
$2.43B
$2.43B
$2.43B
$2.43B
$3.46B
$4.20B
1.24B
1.25B
$1.96
$1.94
Balance Sheet Financials
$16.55B
$5.95B
$34.85B
$51.41B
$12.00B
$23.82B
$26.45B
$38.45B
$12.95B
$-8.78B
$12.96B
1.24B
Cash Flow Statement Financials
$11.15B
$-8.82B
$-3.42B
$7.56B
$6.44B
$-1.13B
$683.00M
$-3.11B
--
Fundamental Metrics & Ratios
1.38
--
--
0.65
2.02
81.07%
41.71%
41.71%
--
36.90%
29.27%
$10.66B
--
--
--
0.16
0.83
1.66
54.29
18.75%
-27.66%
4.72%
6.61%
$10.44
$8.52
$8.91